Advanced Treatment for Lungs and Liver Cancers with Minimal Side Effects
Advanced Treatment for Lungs and Liver Cancers with Minimal Side Effects
Liver and lung cancer brachyablation, also known as interstitial brachytherapy, is a highly targeted form of internal radiation therapy. In this procedure, radioactive sources are placed directly within or near the tumor, offering a precise treatment that effectively controls cancer while minimizing damage to healthy surrounding tissue.
The procedure involves inserting tiny needle , known as brachytherapy applicators, directly into the tumor through CT scan and ultrasonogram guidance. These sources deliver a high dose of radiation to the cancerous cells over a short period of time . The placement is guided by advanced imaging techniques to ensure accuracy, which is crucial for tumors in critical organs like the liver and lungs. After procedure, needles are removed and treatment is completed.
Brachyablation is particularly beneficial for patients with primary liver or lung cancers, as well as those with metastases that are inoperable or resistant to other treatments. The procedure can be used alone or in combination with external radiation therapy, depending on the stage and location of the tumor.
Indications: Brachyablation is indicated for primary liver cancers (such as hepatocellular carcinoma), primary lung cancers, and metastases to these organs from other primary sites.
Procedure: The treatment involves precise placement of brachytherapy catheter into the tumor and delivery of single fraction of radiotheray
Patients undergoing brachyablation often see excellent outcomes, including significant tumor shrinkage, improved survival rates, and reduced symptoms. The precision of this therapy results in fewer side effects and quicker recovery compared to more invasive treatments.
Effective tumor control with minimal complications
Faster recovery and reduced hospital stays
Interstitial brachytherapy for internal mammary node in breast cancer: A case report from our clinic.